# Symbiofilm Trial in Allergic Kids (SYMBIOFILM-TAK)

> **NCT05034328** · — · COMPLETED · sponsor: **Lallemand Pharma AG** · enrollment: 186 (actual)

## Conditions studied

- Common Cold
- Allergy

## Interventions

- **DEVICE:** Healsea® Children
- **OTHER:** Conventional therapies for common cold

## Key facts

- **NCT ID:** NCT05034328
- **Lead sponsor:** Lallemand Pharma AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-14
- **Primary completion:** 2022-11-03
- **Final completion:** 2022-11-03
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2025-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05034328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05034328, "Symbiofilm Trial in Allergic Kids (SYMBIOFILM-TAK)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05034328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*